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Trends in photonic lab-on-chip interferometric biosensors for 
point-of-care diagnostics 
A. B. González-Guerrero,a J. Maldonado,a S. Herranza and L. M. Lechugaa,* 
Portable point-of care (POC) devices for in-vitro diagnostics will be a milestone for the achievement of universal healthcare 
and environmental protection. The main goal is to reach a rapid, user-friendly and highly sensitive portable tool which can 
provide immediate results in any place at any time while having a competitive cost. Integrated optical (IO) waveguide based-
biosensors are the most suitable candidates to achieve this ambitious objective. They are able to operate in real samples (as 
blood, urine, wastewater,..) affording relevant sensitivities even under a label-free scheme. In addition, arrays of IO sensors 
for multiplexed analysis can be integrated in lab-on-chip (LOC) platforms, providing a truly cost-effective fabrication and 
miniaturization. Among the different IO biosensors, interferometric ones have demonstrated the highest sensitivity for label-
free detection ever reported. Although first interferometric biosensors were shown in the early nineties, they focused mainly 
on preliminary proof-of-concept studies; only recently the resilient potential of interferometric biosensors as highly 
advanced POC have firmly emerged. This review provides an overview of the state-of-the art in photonic interferometric 
biosensors, their main biofunctionalisation routes and their integration in LOC platforms, while maintaining a special focus 
on the real analytical applications achieved so far. 
1. Introduction 
The demand for autonomous and portable detection systems 
able to analyse extremely low concentrations of analytes in real 
samples has driven the search for autonomous point-of-care 
(POC) devices 1. POC devices can provide instant results under a 
cost-effective scheme and can enable the sensitive detection of 
biomarkers, with applications in numerous areas, such as 
environmental safety, microbiology monitoring, water 
sanitation, food quality control and clinical diagnosis, among 
others. For example, POC devices could provide a fast 
identification of the most spread diseases such as diabetes, 
stroke, pneumonia, hepatitis A, HIV, malaria or tuberculosis. 
They can be employed as a screening method for metabolic 
disorders and infections and can provide support for adherence 
to treatments. Significantly, POC technologies are opening a 
window of hope for the economically disadvantaged countries 
and low-resource environments, where most of the population 
does not have access to hospitals or clinical laboratories. 
Although considerable advances have been achieved in the 
area of POC devices 1, few of them are commercially available. 
Several technical challenges must be still surpassed to finally 
offer automated, robust, reliable and cost-effective POC devices 
in order to fully explore their potential impact. Issues as 
miniaturization, multiplexing, full-automatization with network 
connection, microfluidics integration, reagents and 
bioreceptors drying and store, are still in the pipeline of the POC 
research and development. However these implementations 
cannot be supported by analytical technologies currently 
employed in diagnostics  despite of their high precision and 
sensitivity.  The main reason is that standard techniques require 
complex procedures, large and costly instrumentation, 
preparation of the samples, and trained personal. Moreover, 
most of them employ florescent labels or amplification steps, 
complicating even more the detection procedure. 
In this context, biosensors can be considered as a real 
alternative to current detection technologies to become part of 
a POC system 2; a biosensor directly detects a specific substance 
from a complex sample by combining a sensitive transducer 
with a selective bioreceptor within the same device, converting 
the specific biointeraction into a measurable signal that can be 
related to the concentration or the presence of the substance 
under analysis. 
Within the large number of existing biosensors, optical ones 
are able to operate in a label-free pattern since they are surface 
mass-sensitive; changes of the light (e.g. intensity, wavelength, 
polarization and phase) can be evaluated when analytes are 
trapped on the sensor surface through the evanescent field. SPR 
biosensor has been and still is the most widely employed optical 
biosensor since it first description in 1983. It has demonstrated 
an outstanding ability to analyse biological interactions. The 
exceptionally high number of publications in plasmonic 
biosensors is a proof of its profound impact, with many and 
diverse interesting results: characterization of carotenoid-
binding proteins 3, analysis of drug discovery processes, quality 
a. Nanobiosensors and Bioanalytical Applications Group. Catalan Institute of 
Nanoscience and Nanotechnology (ICN2), CSIC, the Barcelona Institute of Science 
and Technology and CIBER-BBN, Campus UAB, Ed-ICN2, 08193 Bellaterra, 
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analysis of pharmaceutical compounds 4 and the 
characterization of bacterial carbohydrate antigens 5 to 
mention a few. However, SPR sensor suffers from an intrinsic 
limited sensitivity which can be only improved by adding 
secondary recognition elements 6 at the expenses of losing the 
advantages of a label-free methodology. Moreover, the relative 
large size of SPR-based configurations hinders their 
miniaturisation in POC devices. Later on, Localized Surface 
Plasmon Resonance (LSPR) biosensors 7 were suggested as a 
way to improve the sensitivity while maintaining the 
advantages of label-free sensing. LSPR also allows for 
miniaturization and multiplexing, suitable for POC systems and 
some commercial POC plasmonic systems have emerged 8. 
However, the reported sensitivity for LSPR label-free biosensors 
7 is only slightly better than the one achieved by SPR, being not 
enough for relevant clinical and environmental applications. 
For these reasons, sensors based on integrated optics (IO) 
are attracting increasing attention in the POC diagnostics field. 
They consist of compact waveguides contained on chips which 
can be easily miniaturized with the opportunity to fabricate 
arrays of identical sensors for multiplexed analysis. These IO-
sensor chips can be easily integrated with a polymer 
microfluidics and need very low quantities of a sample (few µL) 
for the analysis. The sensor-microfluidics integration makes 
these systems insensitive to vibrations, a fundamental 
requirement in portable devices. They present other 
advantages such as robustness, reliability and low power 
consumption. Furthermore, due to the reduced dimensions of 
the waveguides (from micrometers to nanometers), several 
sensors can be produced in parallel in the same wafer meaning 
a strong potential for mass fabrication, which significantly can 
reduce the final price of the analysis. 
Main working mechanism of IO biosensors is based on the 
evanescent wave detection principle (see Fig. 1). Part of the 
electromagnetic field of the light confined in the core of a 
waveguide is spread out interrogating a volume of several 
hundred of nanometers over its surface. Any bimolecular event 
taking place on the sensor surface (e.g. the interaction of an 
immobilised bioreceptor with its specific analyte) will change 
the surface refractive index (from nsurface to n’surface) modifying 
the characteristics of the guided light (from Neffective to N’effective). 
This change can be quantitatively related to the concentration 
of the analyte in a sample. 
Different IO arrangements have been proposed during the 
last two decades; most relevant configurations are grating 
couplers, interferometers, microring resonators, photonic 
crystals, silicon wire and slot-waveguides based systems 9. 
Despite all of them are refractive index sensors operating by the 
evanescent field principle, the different physical arrangements 
lead to different quantifiable properties such as the detection 
limit (LOD), one of the most employed parameter to compare 
the performance between different sensors. LOD is defined as 
the minimum variation of refractive index that produces a 
detectable signal which is considered at least three times higher 
than the noise of the experimental system. Two different 
sensitivities can be differentiated: bulk and surface sensitivity. 
The assessment of the bulk sensitivity (i.e. the change in the 
refractive index affecting all the volume occupied by the 
evanescent field) is usually employed to compare the different 
IO transducers and it is expressed as Δnmin, in refractive index 
units (RIU). The surface sensitivity is defined as the variation in 
the refractive index taking place only in a thin layer in proximity 
of the sensor surface, where the biomolecular recognition takes 
place, normally expressed as surface mass density (Г) in pg.mm-
2, which can be calculated by De Feijter’s formula 10.  
Among the different IO sensors, interferometric devices 
show the lowest detection limits (10 -8 RIU for bulk sensing and 
below 0.01 pg.mm-2 for surface sensing) while maintaining the 
requirements of miniaturization, low-cost and label-free 
analysis9, 10. Since these sensors afford the highest sensitivity, 
they are the most attractive for POC devices. Different 
interferometric configurations such as Young, Mach-Zehnder, 
Bimodal Waveguide interferometers and dual polarization 
interferometry have been described in the literature. The 
characteristics of each configuration will be later discussed 
highlighting their strengths and weaknesses. 
However, the final LOD of a biosensor POC device for a 
particular bioapplication is not only due to the physical 
transduction mechanism employed but is also highly dependent 
of the biofunctionalisation protocol. The functionality of the 
bioreceptor layer is a key step in the final performance of any 
sensor device; this receptor layer must interact with enough 
specificity and selectivity with the substance to be detected. For 
that, bioreceptors must be properly attached to the sensor 
surface. First step is to chemically provide the inert surface with 
chemical functional groups, mainly using linking molecules 
Fig. 1 Evanescent field sensing principle. Part of the light confined in a waveguide is spread out outside the core and interacts with the external medium. When the 
refractive index of the surface (nsurface) changes due to a biointeraction (n’surface), the effective refractive index of the waveguide (Neffective) is also modified (N’effective). 
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containing a group reactive to the surface in one end and a 
functional group reactive to the biomolecule in the other end. 
Second step is the bioconjugation of the bioreceptor with the 
ended functional groups of the sensor surface by activating it or 
by using cross-linkers. In addition, unspecific adsorptions are 
always expected when real samples are analysed. The most 
convenient way to reduce such unspecific signals is to design 
bioreceptor surfaces able to suppress the fouling of unspecific 
molecules. The chosen blocking method will depend on the 
matrix complexity of the sample to be analysed (urine, blood, 
serum, sea water…) being blood and serum the biofluids 
presenting the highest fouling levels. Unfortunately, there is not 
a universal method for providing the sensor surface with the 
appropriate bioreceptor layer and depending on the 
application, a custom-designed biofunctionalization procedure 
must be designed. 
In this review, we give a critical overview of the different 
interferometric configuration and their integration in LOC 
platforms. Second, we discuss different functionalisation 
routes, bioconjugation and blocking strategies that can be 
employed to tether the bioreceptors to the transducer surface. 
Following, we extensively explore the different applications 
developed so far using interferometric biosensors. Finally, we 
describe the latest trends in developing truly POC devices using 
this interferometric technology. 
2. Interferometric biosensors 
2.1. Working principle of interferometric sensors 
The extraordinary sensitivity of interferometric devices relies on 
their working principle; the interference of two light waves 
which are experience different optical path lengths. In this 
configuration, one of the light waves is interacting with the 
sample whilst the other one acts as a reference. When both light 
waves interfere, the resulting light wave experiences a phase 
variation proportional to the change in the surface refractive 
index. This phase variation can be related to a bulk refractive 
index change or to a biomolecular interaction if a previous 
receptor layer was included in the sensing arm. In 
interferometry, phase variation is proportional to the 
interaction length of the sample within the evanescent field. As 
a consequence, the sensitivity of a particular interferometric 
configuration can be increased by enlarging the length of the 
sensor area. In addition, the reference arm of the 
interferometric devices can be employed to compensate 
external fluctuations, as for example, the dependence of the 
refractive index with temperature. 
There are two possible configurations for a waveguide 
interferometric biosensor. The first option is that light waves of 
the same wavelength and polarization (sensing and reference) 
propagate by different paths having the same effective 
refractive index (Neff). This is the most employed configuration; 
the Mach-Zehnder (MZI), Hartman (HI) and Young 
interferometers (YI) and the dual polarisation interferometry 
(DPI) fall into this category. The second option is that light 
waves of the same wavelength and polarization propagate by 
the same path having different Neff, as in the case of the 
Bimodal Waveguide Interferometer (BiMW). 
 
2.2. Types of interferometric biosensors 
Mach-Zehnder interferometer (MZI). In a MZI device (see Fig. 2a), 
a polarised and monochromatic light is coupled in a channel 
waveguide and split by a Y-junction into two light beams. One 
of the light beams will travel along the reference arm and the 
other one along the sensing arm interacting with the sample. 
The exiting two light beams are recombined again by another Y-
junction; the resulting light will experience a phase variation if 
a change in the surface refractive index occurs in the sensing 
path. The phase variation will originate a cosine-type variation 
in the intensity of the output light that can be read-out by a 
photodetector or a CCD camera. By using a MZI configuration, 
extremely sensitive sensors have been achieving obtaining a 
LOD of 2×10-8 RIU and 0.01 pg.mm-2, respectively 11. In addition, 
MZI biosensor has a high level of integration since light splitting 
and recombination are made on-chip. The drawbacks of this 
configuration are related to the cosine-type intensity 
distribution of the interference pattern, which involves: i) a 
phase ambiguity of the signal due to its periodicity, ii) possible 
misinterpretation of the signal due to intensity fluctuations of 
the light source and iii) sensitivity fading when the signal is 
tuned close to one of the extreme values of the transmission 
curve.  
The Hartman interferometer (HI). The HI uses slabs waveguides 
(see Fig. 2b). Light is divided into two beams by a splitter outside 
the chip and coupled to the slab waveguide via gratings. Then 
light travels by contiguous regions which are functionalised with 
specific (sensing path) or nonspecific receptors (reference 
path). The light output from both regions are outcoupled using 
gratings and combined by a lens, generating an interferogram 
in a CCD camera. This device has a LOD in the range of 10 -6 RIU 
12. An advantage of this configuration is that the issues related 
to the sinusoidal signal are overcome by the analysis of the 
interferogram by fast Fourier transform (FFT). The main 
limitation relies in the crosstalk effect between sensing and 
reference beams due to the slab waveguide configuration. In 
addition, the lower level of integration of the HI implies a 
complex mechanical stabilization of the optical components for 
a future POC platform. 
The Young interferometer (YI). In a YI (see Fig. 2c), light is coupled 
in a channel waveguide and split by a Y-divisor into two beams; 
one will travel by the sensor area and the other by the reference 
waveguide. The output light from both waveguides is projected 
onto a CCD camera achieving an interferogram which can be 
analysed by FFT. The best LOD achieved with this device has 
been 6×10-8 RIU and 0.02 pg.mm-2, respectively 13. The YI has a 
high sensitivity and unambiguous signals; however the required 
distance between the waveguides output and the CCD makes it 
more prone to vibrations and less suitable for POC integration. 
Dual polarisation interferometry (DPI). This sensor (see Fig. 2d) uses 
two slab waveguides where the lower layer is the reference 
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waveguide and the upper layer is the sensing one 14. An additional 
layer is placed between both waveguides for an effective isolation. 
The intensity distributions from the “up” and “down” waveguides are 
projected into a CCD camera obtaining an interferogram. By using a 
fast liquid crystal switch it is possible to excite the transversal electric 
(TE) and the transversal magnetic (TM) modes in the waveguides at 
the same time. The resulting sensor is able to provide real-time 
information of the biolayer growth obtaining a LOD of 10-7 RIU and 
0.1 pg.mm-2 15. This biosensor was commercialized by the company 
Farfield from 2000 to 2011. 
Bimodal Waveguide interferometer (BiMW). In the BiMW sensor 
(see Fig. 2e), two modes of light of the same polarization and 
wavelength but of different order (TE0 and TE1) travel while 
interfering in a straight waveguide. For this, light is coupled in a 
single-mode waveguide in which only TE0 can propagate; after 
some distance, light is coupled in another waveguide 
supporting two transversal modes. In the step junction, TE0 and 
TE1 are excited and both propagate until the end of the chip. A 
biointeraction will cause a change in the surface refractive index 
that will affect differently to both modes due to the different 
distributions of their evanescent fields. Then, the interference 
of both modes will generate a phase variation producing a 
sinusoidal variation of the intensity distribution of the light 
exiting the waveguide 16. This configuration has demonstrated 
a LOD of 5×10-8 RIU and 2.8 fg.mm-2 17. As the MZI configuration, 
the BiMW device also presents the drawbacks of phase 
ambiguity and sensitivity fading but solves the 
misinterpretation of the signal by normalizing the signals 
output. 
 To summarize this section, the MZI and the YI devices consist 
of channel waveguides which entail a more complex fabrication 
than the devices based on slab waveguides such as the HI. 
However, the signal processing of slab waveguides is more 
difficult for multiplexed detection since parasite light and cross-
talk must be minimized. A different interferometric 
arrangement, the BiMW sensor allows a simpler fabrication 
process than the MZ and the YI since it consists of a straight 
waveguide which avoids the inclusion of Y-splitters. On the 
other hand, MZI and BiMW devices provide a high level of 
integration since splitting and recombination of light are done 
on-chip which provides a further stabilization to mechanical 
vibrations. However, the on-chip recombination of the light 
Fig 2 Schematic diagram of: a) Mach-Zehnder interferometric sensor, b) Hartman interferometer (reprinted from [] Copyright (2002) with permission from Elsevier), c) Young 
interferometer biosensor (reprinted from [] Copyright (2002) with permission from Elsevier), d) dual-polarization interferometer (reprinted from [] Copyright (2004 with 
permission from Elsevier) and e) Bimodal waveguide biosensor. 
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coming from the sensing and the reference arm involves a 
sinusoidal intensity output which drives to an ambiguous signal. 
Despite this drawback is not present in the YI, HI and DPI 
configurations which output interferograms are an 
unambiguous and linear signal; is at the expenses of increasing 
the complexity of the post-processing of the signal. In addition, 
these devices have lower level of integration which can be a 
drawback when considering their incorporation in a POC 
system. 
 
2.3. Lab-on-chip integration for POC platforms 
The multiplexed detection of several analytes from the same 
sample using an array of interferometric sensors can be achieve 
by incorporating in the same platform: i) the in/out-coupling of 
light, ii) the individual microfluidic channels for bringing the 
sample to each of the sensor areas and iii) an appropriate 
modulation system for unravelling the interferometric signal 
and transforming in a linear read-out (only for configurations 
with intensity output). 
Regarding the in/out-coupling of the light, the most 
employed techniques are prim coupling 18, 19, grating-coupling, 
end-fire 16 and butt-coupling 20 since they show a good 
performance for laboratory experiments. However, most of 
them have important limitations for implementing in real POC 
devices due to poor alignment tolerances. A higher alignment 
tolerance has been demonstrated for grating assisted 
coupling21, 22  which is a key point for POC systems in which the 
biochip must be a disposable element.  
The sinusoidal behaviour of the interferometric signal is other 
issue to be solved before integration An option is including 3×3 
couplers 20, 23 and 2×3 multimode interference coupler 24. 
However, these solutions increase the complexity of the MZI 
fabrication process. Alternative approaches developed up to 
now consist of phase compensation techniques such as electro-
optical 25, thermo-optical 26 and magneto-optical 27 modulation 
as well as the use of liquid crystals 28. However, these 
approaches need the use of bulky optical equipment or involve 
additional fabrication steps. Other interesting possibility is to 
periodically modulate the incoming wavelength of a common 
laser diode, introducing a phase variation modification altering 
the Neff of the guided modes. This all-optical modulation 
method has been successfully applied to the MZI configuration 
29 and recently to the BiMW device 30; by using FFT for the 
postprocessing of the signal, a linear and unambiguous 
response can be provided in real-time.  
A different issue is how to bring the liquid sample in contact 
with the sensor area. Microfluidic systems usually employ are: 
i) double side adhesive which bonds the chip with a glass or 
plastic tape including the tubes 31 or ii) polydimiethylsiloxane 
(PDMS) channels fabricated by soft lithography 32. Despite these 
microfluidic systems have a high versatility, their relatively large 
width hinders the evaluation of each sensor independently 
since the minimum separation between waveguides (only few 
hundred of microns or less) is always considered to reduce 
fabrication costs. For this purpose, the fabrication of 
microfluidics channels at wafer level is mandatory for the 
development of a POC device. Moreover, the reduction of the 
fluidic channels can result in an enhanced LOD for a particular 
biapplication by using low sample volumes and by reducing the 
diffusion process 33. Despite all these advantages, the 
integration of the microfluidics with the interferometric sensors 
at wafer level entails a high technological complexity and few 
works have been reported13, 21. 
Taking globally these considerations into account, several 
works have been recently reported demonstrating all of them, 
good approaches for a final POC integration. A frequency-
resolved MZI biosensor (FR-MZI) in which the conventional 
monochromatic laser source is replaced by a white-light source 
has been reported 34. In this case, the use of white-light 
excitation, in addition to be cheaper, circumvents the ambiguity 
and signal fading problems , demonstrating a bulk LOD in the 
range of 10-6 to 10-7 RIU 35. Later, a broad-band light source was 
integrated on the sensor which represented a significant 
progress towards total POC integration. However, this 
implementation was at the expenses of losing sensitivity 
(LOD=10-5 RIU), increasing fabrication complexity and dealing 
again with sinusoidal signals 36. Other important POC 
implementation has been achieved for a MZI device in which 
the sensor arm consisted of a slot waveguide while the 
reference arm consisted of a strip waveguide 31, 37, 38. In this 
sensor, light at 1542 nm was in- and out-coupled by grating 
couplers achieving a LOD of 1.29×10-5 RIU. Recently, an 
asymmetric MZI (aMZI) was proposed in which a small path 
length difference is added between both arms resulting in a 
wavelength dependency of the output phase 39. By scanning the 
aMZI over a small bandwidth it is possible to obtain directly the 
phase shift due to a refractive index change. It can be also 
mention a different MZI configuration in which 850 nm light is 
coupled by grating couplers and an on-chip spectrum analyzer 
(spectral filter) has been incorporated for the read-out of the 
out-coupling light which consists of arrayed waveguide grating. 
The LOD of this device was found in the range of 10 -7 RIU. The 
strong potential of this configuration is that a broadband light 
can be used as source as opposed to an expensive tunable laser. 
In addition, a fully integrated MZI configuration is maintained 
while an interferogram is obtained as output signal. This design 
could overcome the drawbacks related to intensity signals by 
directly obtaining the Δϕ using a proper signal post-
processing40. 
 However, the ideal LOC device for POC multiplexed testing 
must incorporate not only elements for the in- and out-coupling 
of light as grating couplers, a simple system for signal 
modulation and microfluidic channels but also a complete 
sensor array in the same platform . For example, Fig. 3 shows 
different options to the simultaneous light coupling via gratings 
for a multiplexed BiMW biosensor. The first one involves the use 
of several light beams to couple light in a single transducer. The 
second one requires one light beam illuminating a single grating 
but then the waveguide must be splitter to distribute the light 
into the different transducers. The third option is to illuminate 
all the gratings simultaneously. Finally, the multiplexed read-
out can be done with a CCD camera. All these configurations 
have advantages and drawbacks which must be independently 
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examined before a final decision for a competitive POC platform 
can be taken. 
3. Sensor surface functionalisation 
To achieve a specific and sensitive response towards the analyte 
of interest, a recognition element or bioreceptor must be 
previously immobilised on the sensor surface. The 
immobilization procedure will be determined by the material of 
the sensor surface and the reactive functional groups available 
in the bioreceptor, and it must preserve the bioreceptor 
activity, allowing the recognition of analytes while avoiding 
structural damage41. Moreover, the resulting biosurface must 
be inert enough to other interfering compounds normally 
present in the sample matrix. This is of high relevance for label-
free optical biosensors in which nonspecific adsorptions can 
lead to false positive/negative results 42. 
The most common bioreceptors employed in biosensors are 
antibodies, protein derivatives or nucleic acids 43. Other 
biorecognition agents, less commonly employed, are peptides, 
phages, whole cells, aptamers or mimic inorganic structures 
such as molecular imprinted polymers. Antibody/antigen pairs 
have been the most employed system for proof-of concept 
biosensors both in direct (antibody-coated transducer surface) 
44, indirect (antigen-coated transducer surface) 45 or 
competitive assays 46. They have been applied in many areas 
including clinical diagnostics, environmental detection of toxic 
pollutants or food control, to name a few. On the other hand, 
nucleic acid-based biosensors have been applied for pathogen 
detection and infectious disease monitoring, mainly using 
nucleic acid probe hybridization systems. In this case, the sensor 
detects specific segments of nucleic acid, unique within the 
organism of interest, by using complementary sequences as 
bioreceptors. 
Different methods can be used to immobilise the 
bioreceptors on the sensor surface such as physical adsorption, 
covalent, electrostatic or affinity binding 47. Although the direct 
adsorption have been widely used due to its simplicity, it can 
render in poor reproducibility of the receptor density on the 
surface, the molecules adopt a random orientation, and they 
may release from the surface during sample analysis, causing a 
signal loss 48. Hence, the most employed method is the covalent 
bonding 41.  
Different surface modification methodologies for the 
covalent attachment of the bioreceptors have been described. 
We will focus our attention on the modification of silicon-based 
surfaces since they are the main material used for 
interferometric sensors. In the following, we will discuss the 
most applied strategies to chemically modify the transducer 
surface to favour the receptor attachment. We will focus on 
established methods for bioreceptor binding by direct or cross-
linker mediated reactions, with the chemical groups previously 
introduced on the surface. Finally, we provide a brief summary 
of the strategies for achieving functionalised low- or non-fouling 
coated surfaces. 
 
3.1. Surface chemical modification 
Before bioreceptor attachment, the inert surface material must 
be chemically modified to introduce functional groups which 
further facilitate the binding of the bioreceptor. The 
functionalities mainly applied for the chemical modification of 
IO transducers are amine (-NH2), carboxyl (-COOH), thiol (-SH) 
or epoxy, which allow the attachment of the receptor to the 
functional group-ended surface using well-known 
bioconjugation techniques 49. Particularly for silicon and silicon 
nitride materials, the chemical modification strategies can be 
classified in two main groups: i) chemical modification of the 
native silicon oxide layer which is always present on these 
materials, and ii) chemical modification of oxide-free H-
terminated surfaces after etching the native oxide layer. 
Chemical modification of oxidized surfaces. Most of the methods 
applied to chemical modification of IO biosensors are based on the 
molecular grafting of native oxide surfaces, mainly forming self-
assembled monolayer (SAM) of alkyl-silanes 48. This chemistry is not 
limited to Si-based surfaces; other hydroxylated surfaces such as 
metal oxide surfaces as aluminum (Al2O3) 50, titanium (TiO2) 51, or 
tantalum (Ta2O5) 22 can be modified as well by this methodology. 
The oxide layer has hydroxyl moieties (-OH) on its surface that 
can condense with the siloxanes of an organosilane, forming the 
alkyl-silane SAM. However, the density of reactive hydroxyl 
groups on the native oxide layer surface is usually low due to 
the condensation of silanol groups (Si-OH) to form more stable 
siloxane groups (Si–O–Si) over time 52. The most effective 
oxidation techniques for obtaining hydroxyl groups on silicon-
based surfaces are oxygen plasma 53 , piranha solution (mixture 
of concentrated sulfuric acid and hydrogen peroxide at ratios 
from 3:1 to 7:3) 54 and UV/O3 55, although other oxidants such 
as sodium hydroxide 56, nitric acid 57 and mixtures of ammonium 
chloride/hydrogen peroxide and hydrochloric acid/hydrogen 
peroxide 58 can be employed. 
Fig 3 Scheme of the LOC integration of an array of BiMW devices, the microfluidics, 
different options to incoupling the light on the nanowaveguides and the simultaneous 
read-out by CCD camera of four different sensors. 
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The silanisation procedure is carried out by immersing the 
hydroxylated surface into a solution of an alkyl-silane (wet 
chemistry method) or by exposing the surface to a stream of 
alkyl-silane gas generated with pressure reduction and/or heat 
(vapour-phase method). Several parameters as silane 
concentration, type of solvent (in wet chemistry method), 
pressure (in vapour-phase method), temperature and reaction 
time, have a strong influence on the properties (availability of 
functional groups, thickness and density) of the resulting alkyl-
silane layer. For example, when working with the amino-ended 
silane 3-aminopropyltriethoxysilane (APTES), the most widely 
organosilane used for biosensors, experimental wet chemistry 
methods employ from anhydrous organic solvents (such as dry 
toluene 59, dry acetone 60 or dry ethanol 61) to hydro-organic 
mixtures 62 or even water 63. Other alkyl chain organosilanes 
used for biofunctionalisation purposes are 
carboxyethylsilanetriol sodium salt (CTES, carboxylic acid-ended 
surface) 64, 3-glycidyloxypropyltrimethoxysilane (GOPTS, epoxy-
ended surface) 65, 66, isocyanatepropyltriethoxysilane (ICPTS, 
isocyanate-ended surface) 46, 67 or (3-
mercaptopropyl)trimethoxysilane (MPTMS, thiol-ended 
surface) 68. The main employed silanes are schematized in Fig. 
4.  
Due to the simplicity of the method, silanisation has been 
widely employed for functionalization of silicon surfaces. 
However has several drawbacks as the unwanted 
polymerization of the silane molecules which can result in thick 
inhomogeneous films on the surface 69, which could affect the 
performance of the device and the reproducibility of the 
detection. 
Chemical modification of oxide-free H-terminated surfaces. The 
problems of homogeneity and stability of silanes, related to the 
polymerization and hydrolysis of Si–O–Si, stimulated the search of 
alternative methods for grafting functional molecules on oxide-free 
Si surfaces 70. For these alternative methodology, the native oxide 
layer is first removed with concentrated HF to achieve a hydrogen-
terminated surface. To remove the etch products and to clean the 
surface, HF is usually displace with isopropyl alcohol or other non-
oxidant solvent, avoiding milli-Q water rising which may oxidize again 
the surface 71. Finally, the surface is modified either by indirect 
substitution of H-termination by functional organic molecules (such 
as hydrosilylation) or by direct substitution by other atoms or small 
functional groups.  
Despite the number of surface modification protocols based 
on H-terminated described in the literature72-74, their 
implementation for biosensor applications has been until now 
very limited. An example is the work of Gooding et al. which 
describes the formation of carboxylic acid-terminated 
monolayers in porous silicon (PSi) by thermal hydrosilylation to 
develop a label-free protease biosensor 75, 76. Alternatively, 
photochemical hydrosilylation was described by De Stefano et 
al. for the development of DNA PSi-based optical biosensors 77 
and by Maquieira et al., who developed an oxide-free silicon 
nitride surfaces derivatization approach by directly bonding 
glutaraldehyde to surface through N-H bonds 78, later applied to 
microring resonator-based biosensors 79, 80. 
It must be noted that despite they achieve more stable, 
packaged and reproducible monolayers, the functionalisation 
procedures based on oxide-free surfaces modification entail a 
high complexity when compared with standard silanisation 
methods. They require strict anhydrous conditions, the use of 
halogenated solvent and dangerous chemicals such as HF and 
24 h reactions in refluxing conditions under inert atmosphere. 
 
3.2. Bioreceptor immobilisation 
The immobilization of the receptor is usually done by covalent 
binding onto the previously chemically modified sensor surface. 
The strategy employed will depend on the functional group 
present on the surface and the functional group available on the 
bioreceptor for the bioconjugation, being amino groups the 
most frequently employed for both.   
The most common chemistry for covalently immobilised 
bioreceptors onto amine-ended surfaces is based on N-
hydroxysuccinimide (NHS) esters which can react with primary 
and secondary amines to create stable amide and imide 
linkages, respectively 49. However, the preferred cross-linker 
molecule to activate amino-modified supports with 
Fig. 4 Most commonly silanising agents used for chemical modification of silicon-based 
sensor surfaces. 
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isothiocyanate functional groups is p-phenylene 
diisothiocyanate (PDITC). PDITC has the potential to form well-
organized assemblies driven by π-π stacking, significantly 
decreasing non-specific binding 81. Glutaraldehyde has been 
widely employed but it has some undesirable effects, such as 
the formation of several layers that could break during the 
biorecognition process giving inaccurate signals. 
In the case of carboxylate-ended surfaces, they can be 
functionalised with amine-ended bioreceptors after reaction of 
carboxylic acid and NHS in the presence of N-Ethyl-N′-(3-
dimethylaminopropyl)carbodiimide (EDC) and used to couple 
amine-containing bioreceptors 64. 
Bioconjugation of biomolecules to epoxide rings involves 
nucleophilic primary amines, sulfhydryls groups, hydroxyl 
groups 41 to create secondary amine, thioether, or ether bond 
respectively. Finally, thiol-modified surfaces have also been 
described in the literature for attachment of thiolated 
oligonucleotides by disulfide bond 68, or aminated biomolecules 
(antibodies), previously using heterobifunctional cross-linker m-
maleimidobenzoyl-N-hydroxysuccinimide ester (MBS) 82. A 
summary of all these bioconjugations techniques can be found 
in Fig. 5. 
 
3.3. Avoiding non-specific adsorptions 
For POC devices which must operate in real emplacements and 
with crude samples, it is mandatory that the sensor surface is 
resistant to nonspecific adsorption of other molecules in order 
to avoid false results. In interferometric biosensors, reference 
waveguides can be used to subtract unspecific signals from the 
net signal by functionalizing them in the same way that the 
sensing waveguide 83. Using this approach in a Hartman 
interferometer, it was demonstrated the real-time detection of 
an hormone in serum 65 and in undiluted whole human blood 84. 
However, unspecific adsorptions could block the binding sites of 
the immobilized bioreceptors, limiting the receptor/target 
interaction and, consequently, reducing the sensitivity. In 
addition, the fouling effect in both waveguides could not be 
comparable since different bimolecular layers could give rise to 
different amounts of unspecific adsorption 85. The use of 
blocking compounds usually employed in ELISA tests, such as 
proteins (BSA, fish gelatin or casein) or Tween are not always 
working well for plasma or serum blood evaluations using label-
free biosensors. For that, the development of proper non-
fouling surfaces has been in the research focus. Ideally, low-
fouling surfaces for biosensing purposes must provide a 
quantity of non-specific biomolecules adsorbed below the LOD 
of the bioapplication 42.  
Hydrogen bonds, ionic, polar and hydrophobic interactions 
are the main driving forces causing nonspecific adsorption of 
biomolecules on surfaces. As a consequence, the treatment of 
the surface with reagents to increase its hydrophilicity has been 
extensively described to reduce hydrophobic interactions. This 
is the case of poly(ethylene glycol) (PEG) and its derivatives 
which are the most common polymers employed for non-
fouling applications 86. Thereby, oligo(ethylene glycol) (OEG) 
alkanethiols incorporating a functional group such as -COOH 
(HS-OEG-COOH) or -OH (HS-OEG-OH) have been widely used for 
SPR biosensing 87. Recently, PLL-PEG has been employed to 
passivate the glass surrounding gold-nanodisks in a LSPR 
biosensor significantly reducing non-specific binding 88. In this 
direction, poly(ethylene oxide) (PEO) have been employed for 
binding on low fouling amounts from blood plasma and serum, 
respectively 89. Interestingly in this work, the PEO/Dopamine-
melanine layers were growth on silicon oxide surfaces and 
provided the surface with available amino groups suggesting 
Fig. 5 Bioconjugation procedures employed for: a) amine-, b) carboxy-, c) isocyanate-, d) epoxy-, and e) thiol-ended surfaces. 1) BS3-crosslinking, 2) PDITC-crosslinking, 3) 
glutaraldehyde-crosslinking, and 4) EDC/NHS-mediated approaches. 
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that this functionalisation could be employed for silicon-based 
biosensors. 
Electroneutral surfaces made by zwitterionic materials 
could also avoid protein adsorption by a strong hydration via 
ionic solvation 90. This is the case of surfaces covered by a non-
fouling polymer as the poly(carboxybetaine methacrylate) 
(polyCBMA) 91. In addition, this compound provides a high 
quantity of functional groups for the attachment of 
biomolecules. Another CBMA-based material was developed by 
including 3,4-dihydroxy-L-phenylalanine (DOPA), in which two 
DOPA-poly(carboxybetaine methacrylate) (DOPA2-pCBMA2) 
were linked to increase the polymer surface density 92. More 
interesting for interferometric biosensors, the DOPA2-pCBMA2 
has been employed for the functionalisation of a SiO2-coated 
SPR chip via metal-oxygen coordination complex formed 
between DOPA and the oxide surface, following by 
bioconjugation with an antibody 93.  
Although considerable advances have been obtained in the 
development of non-fouling surfaces using PEG and CBMA 
derivatives, the achievement of zero unspecific adsorption at 
the sensitivity level presented by interferometric biosensors is 
still a challenge. 
4. Real applications 
Considering the outstanding sensitivity, potential multiplexing, 
low cost and integration capabilities of interferometric IO 
biosensors, we can envisioned their use for advanced liquid 
biopsies, blood test for detection circulating tumour cells 
(CTCs), detection of mutated DNA fragments or of biomarkers 
liberated to the bloodstream due to the onset of an illness 
before any symptom, among other relevant clinical 
applications. In the case of environmental control, the 
sophisticated and expensive methodologies currently employed 
to detect contaminants which present significant harmful 
effects on the human and animal health using chromatographic 
techniques and/or mass spectrometry detection could be 
replaced by a few minutes assay by introducing the sample in 
an interferometric POC system. The simultaneous detection of 
several analytes, biomarkers or toxins in the same sample is 
other revolutionary aspect that could be afforded by the 
interferometric POC technology. For example, in the clinical 
practice is well-known that a panel of biomarkers can improve 
the predictive performance over individual markers. 
One important advantage of the interferometric POC 
system is the reduction of the analysis price which will enable 
the extension of screening tests for the early detection of 
diseases to a wider range of population. The possibility to place 
autonomous POC devices in primary health care units or even 
at home, could save costs as compare to the current situation, 
where most of the analysis are done in specialised, centralised 
laboratories. 
 
4.1. Clinical diagnostics 
Most of the biomarkers in human biofluids as blood or urine are 
normally present in very low concentrations, well-below the 
ng/mL level, which hinders their label-free detection. 
Interferometric biosensors can afford a label-free detection in 
real-time for such low values of concentration. For example, 
with a BiMW we have detected with a high level of sensitivity, 
the human Growth Hormone (hGH), an important biomarker for 
the diagnosis of acromegaly and other growth disorders. The 
transducer surface was functionalised via CTES silanisation 32. 
The calibration curve for the detection of hGH samples in buffer 
solution using a competitive immunoassay is shown in Fig. 6. 
The LOD was only of 8 pg.mL-1, three magnitude orders better 
than the one obtained with a SPR biosensor (4 ng.mL-1) using 
the same immunoreagents 94. This result indicates the feasibility 
of detecting a particular protein at physiological range in a label-
free way using interferometry. 
Interferometry is also adequate for detecting proteins in 
complex samples. In a recent work, the BiMW biosensor 
performance was demonstrated for the detection of hGH in 
undiluted urine samples using a direct immunoassay format 17. 
In this case, to avoid non-specific adsorption, sensors were 
silanised using APTES and the specific antibody was immobilised 
using a PDITC cross-linker. The biosensor showed a LOD of only 
3 pg.mL-1, without the need of any sample pretreatment or 
amplification steps, proving the label-free detection of hGH at a 
range of concentrations relevant to clinical diagnostics in urine 
(pg.mL-1 range).  
The development of autonomous POC devices would have a 
high impact in developing countries where health care systems 
are not well developed. A prime example is the case of the 
diagnosis of tuberculosis (TB) infection which has the highest 
incidence in countries with low per capita income, and whose 
detection in early states could prevent its spread. Mycobacterial 
culture is now the laboratory standard for the diagnosis of 
active TB, but it is costly and takes weeks to provide the results. 
Interested in solving these issues, Nagel et al. published 22 a 
hybrid YI to detect TB-specific antibodies in blood serum of 
infected persons. Sensor chips were silanised with APTES and 
activated using PDITC to couple the 38-kDa antigen employed 
as bioreceptor. Although the LOD of the sensor was not 
Fig. 6 Calibration curve for the detection of hGH in buffer by a competitive immunoassay 
using a BiMW interferometric biosensor. Inset: scheme of a competitive immunoassay 
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determined, they demonstrated that it was possible to diagnose 
TB-infected patients from their blood samples in a label-free 
way. In the context of TB diagnosis, the European project 
POCKET 40 is developing a low-cost Point-Of-Care test for 
Tuberculosis detection using an fully-integrated MZI 
interferometric approach. The goal of this project is to develop 
a rapid and accurate diagnostic tool for TB diagnosis to be 
applied in resource-constrained settings. The combined 
detection of Lipoarabinomannan (LAM), a bacterial product, 
and Ag85 antigen in urine samples using a POC system is 
proposed to increase the specificity of current flow-lateral tests 
(60%) by a direct immunoassay. 
Until the development of the PCR in the 1990s, virus 
detection methods consisted of culture, antigen detection and 
serology, yielding low overall virus detection rates 95. Although 
PCR is accurate and sensitive, it does not allow a real-time 
detection and has associated a high cost To overcome these 
drawbacks, the detection of herpes simplex virus type 1 (HSV-1) 
was demonstrated by using a multiplexed YI developed by 
MESA+ Institute 96. Three of the four YI channels were employed 
for immobilizing different bioreceptors, demonstrating the 
possibility of measuring multiple analytes from the same 
sample, while the other channel was used as reference. For the 
immobilisation of the antibodies, the sensor areas were 
functionalised by physically adsorbing protein A. They were able 
to detect HSV-1 at a concentration of 850 particles.mL-1, 
claiming a LOD close to single virus detection. The detection of 
HSV-1 in serum samples was demonstrated despite a 
background due to unspecific proteins. 
During last years, microRNA (miRNA), small noncoding RNA 
molecules that regulate gene and protein expression and which 
circulate in human biofluids, have emerged as potential 
biomarkers for the diagnosis of several diseases including 
cardiovascular diseases 97, hepatitis C infection 98 and cancer 99. 
Hence, there is a strong interest in developing POC devices for 
detecting miRNA in a direct, fast and high sensitive way. Liu et 
al. 31 detected several miRNAs (miR-21 and let-7A) in urine 
samples of bladder cancer patients by using a slot-MZI POC 
system. DNA receptors were immobilised following a 
functionalising with APTES. They achieved a LOD of fmol.µL-1 
(equivalent to nM level). Despite the limited sensitivity, the 
miRNAs were detected without amplification from clinical urine 
samples and results were validated by PCR analysis. 
Recently BiMW biosensors have demonstrated ultrasensitive 
detection of microRNAs in complex media 100. Concretely, the 
BiMW biosensor was employed for the detection and 
quantification of miR-181a at attomolar concentrations (LOD = 
23 aM). The extreme selectivity of the biosensor was 
demonstrates by showing the discrimination of homologous 
sequences at the level of single nucleotide mismatch. The 
biosensor was employed for the direct evaluation in human 
urine samples of bladder cancer patients with no need for prior 
sample purification or amplification steps. A significant 
overexpression of miR-181a in bladder cancer patients was 
appreciated when compared with healthy controls, suggesting 
the implication of this miRNA in bladder cancer. These results 
showed that the BiMW biosensor can be used as an 
ultrasensitive and specific diagnostic tool by the early and fast 
detection and quantification of microRNAs for the prediction of 
diseases (such as cancer) with well-defined microRNA 
signatures. 
 
4.2. Environmental control 
Examples in the environmental area includes the detection of 
2,4,6-trinitrotoluene (TNT) in air using the modified-Hartman 
sensor 101 with a molecularly imprinted sol-gel as receptor layer. 
Detection limits for the selective detection of TNT were found 
in the low parts-per-trillion (equivalent to pg.mL-1). Regarding 
the on-line monitoring of water quality, a sensor grid based on 
MZI devices, the EventLab systems by Optiqua Technologies Pte 
Ltd, has been implemented in one of the largest drinking water 
company of The Netherlands. The sensor system (with a bulk 
LOD in the 10-7 RIU range) includes a high density grid of 
integrated MZI devices placed along the distribution network, 
which measured the changes in the water refractive index, 
turning out as an economically viable early warning system. 
Using the same MZI device, they have recently developed and 
validated the MiniLabTM system 102 for detection of Bisphenol A 
in treated water by a competitive immunoassay. Bisphenol A is 
a harmful endocrine disruptor employed in the manufacture of 
plastic materials such as water bottles and food storage 
containers, which can migrate from the packaging to the food 
or drinking water. In this biosensor, immobilisation of Bisphenol 
A on the sensor area was done by functionalising the surface 
with GOPTS silane and further modification with an 
aminodextran. Results demonstrated a working range from 0.5 
to 5 µg L-1 achieving qualitative results by setting a limit of 50% 
normalized response as a cut-off to distinguish between 
“positive” and “negative” samples. In addition, the authors 
claim that the sensor can be reused for more than 200 cycles 
over a 6 months period. Regarding the detection of toxic heavy 
metals ions, it has been demonstrated the real-time detection 
of Hg2+ in water using a DPI with a T-rich oligonucleotide as 
bioreceptor 103. Immobilisation of the receptor was done by 
assembling a highly charged poly(ethylenimine) (PEI) layer on 
the oxidized surface and allowing the negatively charged 
receptor to adsorb on the surface. The LOD was 27 nM which is 
in accordance with the guideline value set by the World Health 
Organization (WHO) for Hg2+ in drinking water (30 nM)104. 
Other interesting example of environmental application is the 
EU project BRAAVOO 105 focused on the development of 
Biosensors, Reporters and Alga Autonomous Vessels for Ocean 
Operation. In this project, a combination of three types of 
biosensors are used to detect a number of marine priority 
pollutants (e.g. algal toxins, heavy metals, organic compounds 
related to oil and antibiotics) as well as biological effects (i.e. 
general toxicity and stress response). The three biosensors were 
first developed as standalone modules and further integrated 
into a buoy and an autonomous unmanned surveying vessel, 
allowing in-situ multianalyte detection in the ocean media. 
Periodic information about the concentration of the monitored 
contaminants will be transmitted via wireless. In this project, 
the BiMW biosensor is being used as a multiplexed 
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immunosensor to assess six specific marine priority pollutants: 
Irgarol 1051, pentabromodiphenyl ether (BDE-47), domoic acid, 
okadaic acid, tetracycline and ampicilline). The biosensor shows 
LODs at µg.L-1 or ng.L-1 levels, depending on the chemical target. 
5. Towards a portable point-of-care device 
The College of American Pathologists defines POC testing 
(POCT) as tests designed to be used at or near the site where 
the patient is located, that nor require permanent dedicated 
space, and that are performed outside the physical facilities of 
the clinical laboratories. In addition to this definition, an ideal 
POC device must be autonomous, i.e. samples must be 
introduced into the device and the outcome must be obtained 
without further pretreatments in order to be employed by 
untrained persons. 
To directly analyse real samples in a direct and label-free 
way by optical biosensors the non-specific adsorption must be 
minimized. Blood samples present an added difficulty since the 
high content of cells could interfere in the analysis and the 
achievement of functionalized surfaces for interferometric 
biosensors presenting zero adsorption is still a challenge. To 
date, removal of the cellular elements of blood have been 
achieved by filtration and centrifugation techniques which 
implies time and costs in medical laboratories. Hence, many 
research groups have developed different alternatives which 
could be integrated in a POC diagnosis system. The most 
popular method is based on microfluidic channels containing a 
bifurcating region in which the cells are separated into the 
branch with less resistance to flow and a faster flow rate (the 
named Zweifach-Fung effect) 106. However, blood must be 
diluted with PBS to reduce the concentration of cells which 
could hinder the detection of low-content proteins. 
Sedimentation based systems have been also reported to 
efficiently extracts blood plasma without diluting the sample 
107. Nevertheless, platelets were found in the extracted plasma 
since they sediment at much lower rates. In a recent 
publication, a continuous flow plasma/blood separator 
consisting of a SiO2 pillar structure with a size gap of less than a 
micron was described 108. Advantages are that it could be 
compatible with lithographic fabrication process of integrated 
optical biosensors and that the design of the filter was found to 
avoid blood-clogging issues. 
Another important issue in the case of bacterial and virus 
identification using biosensors is the necessity of expose their 
nucleic acids to the sensor. For that, bacterial outer membranes 
and viral envelopes must be lysed and DNA or RNA must be 
sheared into an appropriate fragment size. Chemical methods 
commonly used break the membrane by adding detergents or 
surfactants following by DNA purification. However, since this 
procedure is complicated it is difficult to include in a POC 
platform. Alternatively, sonication can be used to disrupt 
cellular membranes and spore coat without adding any 
chemical to the sample which could later interfere with the 
biomolecular recognition process. However, sonicator devices 
are bulky and highly expensive and cannot be integrated in a 
POC device. To overcome this, different small-size sonicators 
have been proposed, either for real-time disruption of bacterial 
cells 109 or for fragmentation of DNA 110. In both cases, standard 
materials were employed and the devices could be integrated 
in POC diagnosis systems. 
Other requirements of an autonomous and low-cost POC 
system are the development of integrated capillary pumps and 
microfluidic valves to avoid costly flowing systems, the 
connections with the macroscopic world, the packaging and the 
storage conditions of individual cartridges chips and the 
wireless connection with mobile phones, doctor offices or 
central data stations. 
Conclusions and outlook 
This review tries to give a complete overview of the main key 
aspects in the development of portable devices using 
interferometric biosensors, from the different available 
transducers to the development of POC systems, going through 
functionalisation techniques and highlighting the more 
advanced bioapplications achieved so far. The different 
interferometric configurations have been briefly introduced 
focusing on different factors: i) to obtain the highest sensitivity, 
ii) to reduce the complexity of the fabrication process, iii) to 
solve the drawbacks associated with the sinusoidal 
interferometric signal and iv) to achieve the highest level of 
integration. We have described the level of development of the 
different components required for light in-coupling, 
microfluidics and modulations systems. All those are recently 
mature technologies that will allow the integration of the 
interferometric transducers in final POC platforms.  
By using interferometric biosensors it has been 
demonstrated the improvement in the sensitivity, for example 
of three order of magnitude as compared to SPR biosensor for 
the same application and without amplification steps. We have 
also shown the direct detection of hGH in undiluted urine at 
relevant physiological levels (few pg.mL-1). In addition, direct 
detection of herpes simplex virus by a YI, miRNA in urine from 
bladder cancer patients by a slot-MZI and diagnosis of TB by 
detecting autoantibodies in blood serum have been 
demonstrated for clinical diagnosis. Regarding environmental 
control, detection of TNT in air by a Hartman interferometer 
Bisphenol A in water using a MZI and Hg2+ in water using DPI 
have been achieved at relevant concentrations. 
Different solutions have been proposed to overcome the 
limitations of development autonomous POC devices. For 
instance, a filter can be integrated on-chip to minimize the 
issues related to the nonspecific signals for blood or other 
complex biofluids and DNA contained in microorganisms can be 
extracted by incorporating a microsonicator. 
The level of development achieve by the interferometric 
technology clearly illustrate the huge potential of 
interferometric biosensors to become part of POC systems in 
the near future for advanced on-site bioapplications. 
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